Areas of Practice: Patents, trademarks, and copyrights; specializing in biotechnology patent prosecution and client.
Dr. Michael B. Farber concentrates in the areas of Intellectual property practice involving patents, trademarks, and copyrights; specializing in biotechnology patent prosecution and client counseling, and opinion work, in genetic engineering, assay devices, gene cloning, monoclonal antibodies, microarrays, biological and medical applications of nanotechnology, genomics, drug discovery and testing, small molecule chemistry with biotechnological applications, and protein and peptide chemistry. Prior to joining the firm, Dr. Farber’s legal experience included working as a patent attorney at both intellectual property firms and general practice firms in Los Angeles and San Diego.
Genomics and Proteomics
J.D., Southwestern University School of Law
Ph.D., Biochemistry and Molecular Biology, Harvard University
B.S., Biology, California Institute of Technology
“Purification and Properties of Bacteriophage X- 174 Gene D Product,” Journal of Virology, 1976, “A Clear-Plaque Mutation of Bacteriophage M13 Affects the Regulation of Viral DNA Synthesis,” Journal of Virology, 1980, “Actual Malice’ and the Standard of Proof in Defamation Cases in California: A Proposal for a Single Constitutional Standard,” Southwestern University Law Review, 1987, “The Scope of Patent Protection for Physiologically Important Proteins and Peptides,” Biopharm, 1990 (with Harris F. Brotman), “’Catch-22’ for Biotechnology Process Patent Protection,” Los Angeles Daily Journal, 1991, “Federal Circuit Tightens Law on Patents for Chemical”